PEAR THERAPEUTICS INC (PEAR)
US7047231052 - Common Stock
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash Equivalents | 48.30M | 169.57M | N/A | |||
| Marketable Securities | 10.97M | 5.00M | N/A | |||
| Receivables | 6.94M | 1.79M | N/A | |||
| Other Current Assets | 6.74M | 8.88M | N/A | |||
| Total Current Assets | 72.96M | 185.24M | N/A | |||
| Non-Current Assets | ||||||
| PPE Net | 14.96M | 6.25M | N/A | |||
| Other Non-Current Assets | 7.21M | 5.66M | 310.45K | |||
| Total Non-Current Assets | 22.17M | 11.92M | N/A | |||
| TOTAL ASSETS | 95.13M | 197.16M | 310.45K | |||
| LIABILITIES | ||||||
| Current Liabilities | ||||||
| Short Term Debt | 0.00 | 0.00 | 45.53K | |||
| Current Portion Of LT Debt. | 27.45M | 26.99M | N/A | |||
| Accrued Expenses | 16.61M | 16.17M | 240.45K | |||
| Accounts Payable | 3.26M | 1.81M | 1.65K | |||
| Other Current Liabilities | 2.12M | 2.20M | N/A | |||
| Total Current Liabilities | 49.44M | 47.17M | 287.63K | |||
| Non-Current Liabilities | ||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 15.10M | 59.56M | N/A | |||
| Total Non-Current Liabilities | 15.10M | 59.56M | 0.00 | |||
| TOTAL LIABILITIES | 64.54M | 106.73M | 287.63K | |||
| SHAREHOLDERS' EQUITY | ||||||
| Retained Earnings | -323.47M | -247.98M | -2.18K | |||
| Additional Paid In Capital | 354.09M | 338.40M | 24.43K | |||
| Common Shares | 14.00K | 14.00K | 580.00 | |||
| Other Shareholders' Equity | -47.00K | -1.00K | N/A | |||
| Shares Outstanding | 140.45M | 137.84M | 30.90M | |||
| Tangible Book Value per Share | 0.22 | 0.66 | 0.00 | |||
| Total Shareholders' Equity | 30.59M | 90.43M | 22.82K | |||
| TOTAL LIABILITIES AND EQUITY | 95.13M | 197.16M | 310.45K | |||
| Statistics | ||||||
| Current Ratio | 1.48 | 3.93 | N/A | |||
| Return On Assets (ROA) | -79.36% | -33.04% | -0.70% | |||
| Return On Equity (ROE) | -246.82% | -72.03% | -9.55% | |||
All data in USD